Login

Exclusive Interview with Doxa CEO Jan Edöcs at Geneva - Jan Edöcs, CEO, Doxa 00:00:00

Share On Facebook Share On Twitter

Exclusive Interview with Doxa CEO Jan Edöcs at Geneva

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Interview with the Managing Director of ARSP Mr. Miguel | Miguel KATEMB KASHAL, MANAGING DIRECTOR, ARSP
00:10:00
First Impressions and Insights from the One-to-One Mining Conference in New York
00:10:00
Golden Arrow's Exploration Success in Chile
00:10:00
Mastering Your Money: Aligning Goals and Overcoming Fears | Joe Pantozzi , President , Alpha Omega Wealth Management LLC.
00:10:00
Scott Kettle: Innovating Global Digital Distribution with Gawk Incorporated
00:10:00
Musgrave Minerals: Advancing High-Grade Gold Discoveries in Western Australia
00:10:00
Exploration Update and Prospects in Colombia's Mineral-Rich Choco Region
00:00:00
Oxurion: Developing Innovative Therapies for Diabetic Eye Disease - Patrik De Haes, CEO, Oxurion
00:10:00
Joel Chamberlain Discusses Community Involvement and Leadership with Alex Kellison
00:10:00
Shaping Africa's Future: Bridgewater's Call to Action | Nir Bar Dea, CO-CEO , Bridgewater Associates LP.
00:10:00
Atlantic Lithium's Aweré Project in Ghana: Expanding Resources and Promising Scoping Study Results
00:00:00
Elias Papatheodorou, CEO of Genkyotex, tells us more about his relationship with the BioDiscovery team

© 2017 - Neuhu+